In contrast, the luminal miRNAs targeted transcription factors that controlled EMT (ZEB1/2), and biomarkers associated with fibrosis and actin cytoskeleton (collagens), and basal cancer biology (IL6, EGFR, STAT3), all of which are suppressed in luminal cancers. The gene discussed is ZEB1; the disease is cancer.